Summary:
- Researchers at the RIKEN Center for Integrative Medical Sciences have identified a specific protein, GPR31, that acts as a receptor for gut bacteria-derived metabolites.
- This discovery explains how certain gut microbes promote the repair of the intestinal lining, offering potential therapeutic targets for treating inflammatory bowel diseases like ulcerative colitis.